|
FY2025
12 months to Sep 30, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net income | |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Bad debt written off | |
| Depreciation | |
| Provision of expected credit losses | |
| Amortization of operating lease right-of-use assets | |
| Deferred tax benefits | |
| Change in operating assets and liabilities: | |
| Accounts receivable, net | |
| Prepaid expenses | |
| Other assets, net | |
| Accounts payable | |
| Contract liabilities | |
| Income tax payable | |
| Operating lease liabilities | |
| Accrued expenses and other liabilities | |
| Net cash used in operating activities | |
| Cash flows from financing activities: | |
| Proceeds from issuance of common shares pursuant to IPO, net of offering costs | |
| Proceeds from bank loans | |
| Repayments of bank loans | |
| Payments of offering costs related to IPO | |
| Repayment to related parties | |
| Net cash provided by (used in) financing activities | |
| Net increase (decrease) in cash and cash equivalents | |
| Effect of exchange rate changes on cash and cash equivalents | |
| Cash and cash equivalents, beginning of year | |
| Cash and cash equivalents, end of year | |
| Supplemental disclosures of cash flow information: | |
| Income tax paid (refund) | |
| Interest received | |
| Interest paid | |
| IPO offering costs paid | |
| Supplemental disclosures of non-cash information: | |
| Deferred IPO cost charged to additional paid-in capital |
Loading...
